Common Contracts
2 similar Note Conversion Agreement contracts by Cingulate Inc.
NOTE CONVERSION AGREEMENTNote Conversion Agreement • January 29th, 2024 • Cingulate Inc. • Pharmaceutical preparations • New York
This Note Conversion Agreement (this “Agreement”) is made and entered into as of January 25, 2024 (the “Effective Date”), by and among Cingulate Therapeutics LLC, a Delaware limited liability company (the “Company”), Cingulate Inc., a Delaware corporation (the “Parent”) and Werth Family Investment Associates LLC, a Connecticut limited liability company (the “Holder”).
NOTE CONVERSION AGREEMENTNote Conversion Agreement • September 11th, 2023 • Cingulate Inc. • Pharmaceutical preparations • New York
This Note Conversion Agreement (this “Agreement”) is made and entered into as of September 8, 2023 (the “Effective Date”), by and among Cingulate Therapeutics LLC, a Delaware limited liability company (the “Company”), Cingulate Inc., a Delaware corporation (the “Parent”) and Werth Family Investment Associates LLC, a Connecticut limited liability company (the “Holder”).
